Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 29
Selected: 0
NCT IDTitle
NCT07295873Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide
NCT05704166PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
NCT05905172Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
NCT07263152QTc Assessment in a Single-Dose Study of Hydronidone Capsules
NCT05280873Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
NCT07471217[¹⁴C] Hydronidone Mass Balance Study
NCT04820049F573 Ia Clinical Trial
NCT05115942Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
NCT07417553A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
NCT05288179Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
NCT07262346The Phase Ⅰd Clinical Trial of Hydronidone Capsules
NCT05689645F573 for Injection for the Treatment of Liver Injury/Failure
NCT04125056Study on Hydronidone Capsule BE
NCT07412236A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
NCT07394309Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
NCT04126538Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics
NCT07262333A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
NCT05531955Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
NCT04124081Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects
NCT04162821Study on Pharmacokinetics of Hydronidone
NCT06899815Preliminary Human Trials of F230 Tablets
NCT03857854Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)
NCT04123769Study on PK of Hydronidone in Patients and Special Population
NCT02296281Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury
NCT03902509A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.
NCT07364448A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
NCT07343778A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
NCT03856853Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease
NCT07388680Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia